Hyderabad: IT Minister KT Rama Rao announced the eagerly awaited BioAsia 2024, scheduled to take place from February 26th to 28th, 2024. This 21st edition of BioAsia promises to be an extraordinary platform where Data and AI converge to redefine possibilities across the life sciences and healthcare sectors.
Themed “Data and AI: Redefining Possibilities,” BioAsia 2024 will explore the pivotal role of data-driven technologies and artificial intelligence in shaping the future of healthcare, pharmaceuticals, and biotechnology. As the world increasingly harnesses the power of digital innovation, the theme aptly underscores the immense potential that lies at the intersection of technology and life sciences.
Minister KT Rama Rao’s signature statement, “Hyderabad is the place where Technology meets Biology and Data Sciences meets Life Sciences,” captures the essence of the city’s prowess in marrying cutting-edge technology with life sciences expertise. BioAsia 2024, being organized in partnership with EY, will delve deep into how the fusion of data sciences and life sciences can usher in transformative breakthroughs, paving the way for a healthier and more sustainable future.
BioAsia has consistently risen as a global platform that fosters meaningful dialogues among industry leaders, policymakers, researchers, and innovators. BioAsia 2024 is set to elevate this legacy by assembling influential global leaders and participants from more than 50 countries, fostering collaborations and partnerships that transcend geographical boundaries.
Speaking about BioAsia 2024, Minister KTR said, “BioAsia has always been a catalyst for transformative ideas and partnerships. The theme of Data and AI speaks to Hyderabad’s unique convergence of technology and life sciences, shaping a new era of healthcare innovation. This flagship event is a testament to our commitment to fostering collaborations that drive progress and impact on a global scale. With the world’s leading minds converging in Hyderabad, we are set to explore the uncharted frontiers of this transformative era.”
“In an era marked by breakthroughs in genomics, precision medicine, and digital health, the convergence of data and AI promises to reshape research, diagnostics, treatment, and patient care. This year’s theme encapsulates the profound impact of data-driven technologies and artificial intelligence on the trajectory of healthcare, biotechnology, pharmaceuticals and medical devices. BioAsia 2024 will unlock new dimensions in the world of life sciences and healthcare through the lens of Data and AI. It’s an event not to be missed” said Shakthi M.Nagappan, CEO of Telangana Lifesciences and BioAsia, Government of Telangana.
Data and AI are the driving forces behind cutting-edge advancements that have the potential to redefine healthcare possibilities globally. BioAsia 2024 promises to be a landmark event that will set the stage for meaningful conversations, innovations, and collaborations, driving the life sciences and healthcare sectors to new horizons. This event encapsulates the spirit of innovation and convergence that Hyderabad embodies.
“BioAsia 2024 is the embodiment of our vision to harness the potential of Data and AI to redefine healthcare possibilities globally. BioAsia is the perfect platform to explore the synergy between Data, AI, and Lifesciences, propelling us into a future of transformative healthcare” said Jayesh Ranjan, IAS, Principal Secretary (I&C), State Government.
With the energetic city of Hyderabad as the backdrop, BioAsia 2024 promises to be an epicentre of forward-thinking ideas, groundbreaking innovations, and influential partnerships that will shape the future of life sciences and healthcare globally. In addition to influential global leaders from various sectors, the event will mark the presence of over 50 countries, fostering cross-border collaboration that drives innovation. Minister also unveiled the website for the event www.bioasia.in/2024 with the event information.
“Artificial intelligence and machine learning are exerting a transformative effect on the life sciences industry. Gen AI, the recent buzzword is a new addition to the list of transformative forces. Though at an early stage of adoption, the life sciences industry is likely to find numerous future use cases of these transformative technologies which could be the realm of imagination today. BioAsia 2024’s theme “Data and Artificial Intelligence: redefining possibilities” will further unleash and unravel those exciting possibilities of technology in unlocking the power of data. BioAsia has been the landmark global life sciences event in bringing together life sciences and health care sector stakeholders across the globe to review trends and opportunities for creating a successful life sciences economy. We at EY are delighted to be associated as the knowledge partner for the event and contribute to this transformative journey.” said Suresh Subramanian, Partner and National Life Sciences Leader, at Ernst & Young LLP. (INN)